The diversity of Aspergillus species in clinical samples is continuously increasing. Species under the former name Eurotium, currently accommodated in section Aspergillus of the genus Aspergillus, are xerophilic fungi widely found in the human environment and able to grow on substrates with low water activity. However, their prevalence in the clinical setting is poorly known. We have studied the presence of these species in a set of clinical samples from the United States using a multilocus sequence analysis based on the internal transcribed spacer (ITS) region of the rRNA, and fragments of the genes β-tubulin (BenA), calmodulin (CaM), and polymerase II second largest subunit (RPB2). A total of 25 isolates were studied and identified as follows: A. montevidensis (44%), A. chevalieri (36%), A. pseudoglaucus (8%), and A. costiformis (4%). A new species Aspergillus microperforatus is also proposed, which represented 8% of the isolates studied and is characterized by uniseriate conidial heads, subglobose to pyriform vesicles, rough conidia, globose to subglobose cleistothecia, and lenticular and smooth ascospores. The in vitro antifungal activity of eight clinically available antifungals was also determined against these isolates, with the echinocandins and posaconazole having the most potent activity.
Introduction
The number of species of Aspergillus involved in human infections is continuously increasing, and most of these species have nowadays been identified using modern molecular techniques. Until recently, the dual nomenclature system permitted different names for the sexual and asexual forms of Aspergillus. One such example is the genus Eurotium, the name for the sexual state for species in the former Aspergillus glaucus group. 1 However, following the and former species of Eurotium now comprise the aspergilli in the section Aspergillus. 4 A new approach to phylogenetic study supports the current broad concept of the genus Aspergillus, 5 with A. glaucus (= E. herbariorum) being the type species of the genus. Species in the section Aspergillus are usually osmophilic, with optimum growth on substrates with high sugar or salt concentrations. Commonly the asexual morph has smooth conidiophores, with uniseriate, radiate to somewhat columnar conidial heads, and ellipsoidal to globose echinulate conidia. 1, 6 The sexual morph is usually characterized by globose to subglobose, thin-walled cleistothecia, eight-spored asci, and lenticular, smooth to roughwalled ascospores, generally showing an equatorial line or furrow. 1, 7 These species are found worldwide and often on organic materials, dust, and stored cereals and other food products. 1, 7 Although these aspergilli are of minimal clinical importance, some, such as A. glaucus, have been reported in orofacial 8 and brain infections. 9 In addition, A. montevidensis has been involved in cases of otitis, mycetoma, cerebral abscess, keratitis, and pulmonary infections, 10 and A. glaucus and A. montevidensis can also cause hypersensitive pneumonitis 11, 12 . Aspergillus chevalieri and A. pseudoglaucus have been linked to cutaneous aspergillosis 13 and maxillary sinusitis, 14 respectively. Hubka et al. 15 recovered five species of section Aspergillus among isolates from probable cases of superficial infections (e.g., skin and nails), including A. montevidensis, A. costiformis, A. pseudoglaucus, A. proliferans, and A. ruber in Czech Republic. The antifungal susceptibility patterns of members of section Aspergillus are largely unknown, 16 with little published data. Masih et al. 17 demonstrated potent activity of posaconazole, anidulafungin, and micafungin against three strains of A. montevidensis (GM minimal inhibitory concentrations [MICs] of 0.04 μg/ml, 0.015 μg/ml, and 0.015 μg/ml, respectively) and one of A. chevalieri (MICs of 0.015 μg/ml, 0.03 μg/ml, and 0.015 μg/ml, respectively). García-Martos et al. 18 also demonstrated low MIC values for amphotericin B, itraconazole, and voriconazole against three strains of A. glaucus (MICs of 0.125-0.5 μg/ml, 0.25-0.5 μg/ml, and 0.125-0.25 μg/ml, respectively) and against two strains of A. chevalieri (MICs of 0.125-0.5 μg/ml, 0.125-0.25 μg/ml, and 0.125-0.25 μg/ml, respectively).
Wildfeuer et al. 19 tested eight strains of A. glaucus against four drugs and observed that itraconazole exhibited the most potent activity (GM MIC of 0.39 μg/ml). In order to assess the diversity of species from Aspergillus section Aspergillus in the clinical setting and to observe their response to antifungal drugs, the aim of this study was to identify to the species level a set of clinical isolates from the United States using a multilocus phylogenetic study, and to determine the susceptibility pattern of eight clinically available antifungals against these species.
Methods

Fungal isolates
A total of 25 isolates of section Aspergillus were investigated in this study. Most of them were from human clinical samples, primarily from the respiratory tract (BAL, sputum, and sinus), but also in fewer numbers from corneas, nails, stool, and lymph nodes. One of them was of environmental origin, and the origin of four were unknown (Table 1) . These isolates were received at the Fungus Testing Laboratory of the University of Texas Health Science Center (San Antonio, TX, USA) from different institutions across the United States over a period of 11 years (2004-2015) , for identification and/or antifungal susceptibility testing.
Morphological characterization
The morphology of the fungi was characterized by the traditional criteria. 4, 20 Microscopic features were examined and measured on MEA and CY20S cultures, after 10-14 days of incubation, on wet mounts with 60% lactic acid and a drop of ethanol 70% to wash out the excess conidia. Photomicrographs were taken with a DeltaPix Infinity X digital camera mounted on a Zeiss Axio Imager M1 light microscope (Zeiss, Oberkochen, Germany), using a Nomarski differential interference contrast and phase contrast optics. Scanning electron microscope (SEM) photographs were taken with a Jeol JSM-6400 using techniques described previously.
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DNA extraction, amplification, and sequencing
Total genomic DNA was extracted from MEA cultures after 7 days of incubation at 25
• C, using the FastDNA R Kit and the FastPrep R Instrument (MP Biomedicals, Irvine CA, USA), according to the manufacturer's specifications. After extraction, four different genetic regions were amplified for each strain 20, 23 ; that is, the internal transcribed spacer (ITS) region of the rRNA, comprising ITS1, 5.8S gene, and ITS2 regions, using ITS5 and ITS4 primers 24 ; a portion of β-tubulin gene (BenA), using Bt2a and Bt2b primers 25 ; a portion of calmodulin gene (CaM), using Cmd5 and Cmd6 primers 26 ; and a portion of RNA polymerase II second largest subunit gene (RPB2), using 5F and 7CR primers. 27 Polymerase chain reaction (PCR) products were sequenced in both directions, using the same primers, at Macrogen Europe (Macrogen Inc., Amsterdam, the Netherlands). Sequences were assembled and edited using SeqMan v.7.0.0 (DNASTAR, Madison, WI, USA).
Molecular identification and phylogenetic analysis
The phylogeny was analyzed first individually for each partition and then in a concatenated study, once the topologies proved to be congruent. To give support to our analyses, sequences of the ex-type strains of all species of section Aspergillus obtained from GenBank were also included, and A. halophilicus (section Restricti) was used as the outgroup.
To increase the robustness of the A. pseudoglaucus clade, sequences of 15 other strains of this species were additionally retrieved from GenBank and included in the analyses. A multiple sequence alignment was performed using ClustalW inside MEGA v.6 software. 28 When necessary, the MUSCLE tool and manual adjustments were used to refine the alignment. Maximum Likelihood (ML) was conducted with MEGA v.6 software, as well as the estimation of the best nucleotide substitution method. Support values of the internal branches were assessed using the Bootstrap method with 1000 replications (values equal or higher than 70% were considered significant). Bayesian inference (BI) was performed using MrBayes v.3.1.2 software. 29 The evolutionary models that best fit each partition were assessed by MrModel Test software. 30 Markov chain Monte Carlo (MCMC) sampling was performed with two simultaneous runs for 1 million generations, with samples taken every 100 generations. The 50% majority rule consensus trees and posterior probability values (pp) were calculated after removing the first 25% of the resulting trees for burn-in. Values of 0.95 or higher were considered significant.
Antifungal susceptibility testing
The isolates were tested against eight antifungals, following the microdilution broth method. 31 The antifungal agents 
Nucleotide sequence accession numbers and alignments
Newly generated sequences from this study have been deposited in GenBank/EMBL databases under the accession numbers listed on Table 1 . The alignments were deposited in TreeBASE (submission number S20583).
Results
In the present study, as expected, the ITS region was the least informative marker, being unable to discriminate some of the species included in the analysis (Fig. S1 in The morphology of the isolates shows the expected phenotypic characters that agree with the previous species descriptions. 1, 4, [32] [33] [34] Aspergillus montevidensis exhibits rough ascospores, with irregular crests; A. chevalieri shows smooth ascospores, with prominent crests; A. costiformis is the only species with smooth conidia; and A. pseudoglaucus and A. microperforatus demonstrated smooth ascospores, with no crests, and rough conidia. In fact, these last two species have a similar morphology, being differentiated by the slow growth and restricted sporulation of the novel species on CYA at 25 • C and on M60Y at 37
• C and the absence of soluble pigment in any of the culture media tested. Aspergillus pseudoglaucus isolates identified here grew and sporulated well on both media and temperatures, and produced a brownish soluble pigment on CYA at 25
• C in 14 days of incubation. Table 2 shows the key phenotypic features of the species of genus Aspergillus already reported in clinic, including those recovered in this study.
In general, all isolates were inhibited by each of the antifungal drugs tested, with overall geometric mean (GM) values lower than 1.0 μg/ml. The most potent activity was observed with the echinocandins (GM of 0.03 μg/ml), while VRC had the highest MIC values (GM of 1.0 μg/ml for A. pseudoglaucus, and 0.77 μg/ml for A. montevidensis, with individual values up to 2.0 μg/ml). The results of the in vitro susceptibility test are summarized in Table 3 . Colonies on CYA 8-15 mm diameter in 7 days at 25 Conidiophores up to 550 μm long, with uniseriate and radiating conidial heads; stipes occasionally septate, 260-500 × 6.5-9.5 μm, hyaline to subhyaline, smooth to finely roughened; vesicles subglobose to pyriform, 24-36 μm diameter; phialides variable in shape and size, ampulliform to cylindrical, 7-18 (30) × 2-5 μm; conidia globose to elongate, sometimes pyriform, 6-9.5(-11) × 4.5-9 μm, in shades of brown, rough. Cleistothecia globose to subglobose, 90-130 μm diameter, light yellow (2A5) to deep yellow (4A8); asci globose, 10-14 μm in diameter; ascospores lenticular, 4-5.5 × 2.5-4.5 μm, hyaline, with a slight furrow in the equatorial region, convex surface smooth with very small pits only visible under SEM. 
Etymology
Referring to the presence of small pits in the ascospore wall under SEM. 
Discussion
Although the diversity of genus Aspergillus species is well known in osmophilic substrates, house dust, indoor air, or stored products, in the clinical setting it is poorly documented. As previously noted, the taxonomy and nomenclature of the species of section Aspergillus has recently changed. In addition to that, recent advances in molecular tools have allowed for the description of new cryptic species that are almost impossible to differentiate using classical morphological tools. 35 Clinically, identification of Aspergillus isolates at the species level may be important given that susceptibilities to antifungal drugs vary for different species and that species identity can influence the choice of appropriate antifungal therapy. 36 In the present study, a total of 25 isolates of genus Aspergillus were used, most of them being recovered from human respiratory specimens, although further studies are needed to elucidate the role of these fungi as pathogens. Five different species of the section have been identified here, including a novel one (i.e., A. chevalieri, A. costiformis, A. microperforatus, A. montevidensis and A. pseudoglaucus). To facilitate comparison, their key morphological features are presented in Table 2 .
Aspergillus montevidensis was the most prevalent (44%). Clinically, this species may be the most relevant pathogen of this group because it has been isolated from different bodies sites, from superficial to deep tissue infections. 10, 15, 37 It was first reported and described from a case of human otomycosis. 38 This species currently includes strains that were formerly accepted as different but now considered conspecific. Aspergillus hollandicus (incorrectly associated to the sexual state Eurotium amstelodami), A. heterocaryoticus, and A. vitis are all synonyms of A. montevidensis, and these names should no longer be used. 4 The nine isolates of A. montevidensis in the present study, with the exception of two of unknown origins, were from respiratory specimens (i.e., sputum, sinuses, and lung biopsies).
The second most prevalent species in the present study is A. chevalieri (36%), known until recently by its teleomorph name, Eurotium chevalieri. This species has been reported from a case of cutaneous aspergillosis 13 and more recently was the cause of fatal cerebral aspergillosis acquired by traumatic inoculation. 17 It is worth noting that A. chevalieri and A. montevidensis represent 80% of the isolates included in this study, in fact they are also some of the most commonly species found in indoor environments. 4 These two species, and the others reported here, were able to grow well at 37
• C in vitro (Table 2) , the basic pathogenic feature that enables them to invade deep tissue. 39 The isolate of A. costiformis identified in this study is the third known strain of this species since its description. It was originally recovered from a mouldy paper-box in China. 34 The second strain was isolated from a human nail in the Czech Republic, 15 and the present study has recovered a third strain from hospital environment. The difficulty in the phenotypic characterization of this species might explain why it is rarely reported. The key characteristic that identifies A. costiformis is the presence of smooth conidia (Table 2 ) and the asexual morph is not usually formed in standard culture conditions. To overcome this problem, the production of conidial heads can be induced on M60Y at 37
• C, as previously reported. 4 The remaining isolates included in this study were genetically and morphologically similar but they could be distinguished as two different species (each representing 8% of the isolates). First, isolates UTHSCSA DI15-17 and UTHSCSA DI16-410 were identified as A. pseudoglaucus, a species described by Blochwitz in 1929. 33 This species was more recently delineated phylogenetically by Hubka et al. 4 in whose study other species were shown to be conspecific with A. pseudoglaucus, that is, A. glaucoaffinis/E. pseudoglaucum, 40 A. glaber, 40 A. fimicola, 41 and A.
reptans/E. repens. 40 The phylogenetic tree constructed in the present study includes sequences of the ex-type strains of synonymous species and of numerous reference strains, giving more support to the A. pseudoglaucus clade. Our analysis shows that the genetic similarity among all those strains is 99.9% or higher in the concatenated alignment, in agreement with the proposal mentioned above. Aspergillus pseudoglaucus is commonly found in stored products 7 and produces metabolites that are potentially toxic. 42 There are few clinical reports involving A. pseudoglacus; it has been reported from a mixed infection in a case of maxillary sinusitis 14 and occasionally recovered from human skin and nails, 15 although its pathogenicity has not been confirmed. The two isolates of A. pseudoglaucus identified in the present study were from nasal and stool samples. Second, the isolates UTHSCSA DI16-400 and UTH-SCSA DI16-407, recovered from toenail and lymph node, respectively, and sequences of two isolates retrieved from GenBank group in a clade close to A. pseudoglaucus. Although these latter isolates were labelled as A. pseudoglaucus, both phylogenetic methods (ML and BI) and the three most informative markers (BenA, CaM, and RPB2) all show that they represent together with our isolates investigated a distinct lineage in the genus. 4 43, 44 However, the limited number of isolates of other species available in different clinical laboratories precludes the determination of epidemiologic cutoff values, and members of genus Aspergillus have only been rarely tested for antifungal susceptibility. 16 With few exceptions, the eight antifungals used in this study showed good activity against the aspergilli tested, with MIC values equal to or less than 1.0 μg/ml (Table 3) . Recently, Masih et al. 17 provided the in vitro antifungal susceptibility profiles of rare Aspergillus species in clinical samples from India. Although they did not test TBF, the MIC values for the other seven antifungals against three isolates of A. montevidensis and one strain of A. chevalieri were similar to the values observed in the current study. Most available in vitro data are with A. glaucus. Wildfeuer et al. 21 and García-Martos et al. 22 include eight and three clinical isolates of A. glaucus, respectively, and both reported good activity for ITC (MIC range of 0.25-0.5 μg/ml), VRC (0.125-0.78 μg/ml), and AMB (0.125-1.56 μg/ml). Although we did not study any A. glaucus strains, these values are similar to the overall values observed for the strains tested here. However, our MIC values were slightly lower for AMB and higher for VRC. Furthermore, García-Martos et al. 21 also included two isolates of A. chevalieri and report the same MIC range (0.125-0.25 μg/ml) for ITC, VRC, and AMB. These results are very similar to those found in our A. chevalieri isolates, with the exception of one isolate that had an ITC MIC of 1.0 μg/ml. In summary, this study has assessed the species diversity of genus Aspergillus from a set of clinical isolates from the United Statesand demonstrated that A. montevidensis and A. chevalieri were the most frequently identified species. We also describe A. microperforatus as a new species. The antifungals tested showed potent activity against these isolates, especially the echinocandins and PSC.
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